secwatch.observer — SEC 8-K summary
======================================

Issuer:     Anebulo Pharmaceuticals, Inc. (ANEB)
CIK:        0001815974
Form:       8-K
Filed at:   2025-02-12T23:59:59+00:00
Accession:  0001493152-25-006036
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Anebulo sets 2025 annual meeting for April 4; stockholder proposals due Feb 22
------------------------------------------------------------------------------

- Annual Meeting scheduled for April 4, 2025; location to be in proxy materials.
- Stockholder proposals for inclusion in proxy must be received by February 22, 2025.
- Director nominations and other proposals not in proxy also due by February 22, 2025.
- Universal proxy rule compliance deadline is February 22, 2025 (10 days after 8-K filing).
- Meeting date more than 30 days after prior year's anniversary, resetting prior deadlines.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1815974/000149315225006036/0001493152-25-006036-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1815974/000149315225006036/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-006036

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer